v3.24.0.1
Stockholders' Equity - Additional Information (Detail) - USD ($)
$ / shares in Units, shares in Millions
12 Months Ended
Oct. 31, 2019
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
May 08, 2020
Dec. 31, 2019
Stockholders Equity [Line Items]            
Unrecognized compensation costs related to unvested stock options, (RSUs) and (PSUs)   $ 71,400,000        
Recognition period of unrecognized compensation expense   1 year 10 months 24 days        
Capitalized equity-based compensation costs   $ 0        
Intrinsic value of options exercised   0        
Equity-based compensation   $ 47,300,000 $ 61,100,000 $ 79,600,000    
Restricted Stock Units (RSUs) [Member]            
Stockholders Equity [Line Items]            
Weighted average grant date fair value per unit   $ 4.57 $ 8.05 $ 20.16    
Fair value of stock vested   $ 53,800,000 $ 67,100,000 $ 74,100,000    
Restricted Stock Units (RSUs) [Member] | Maximum [Member]            
Stockholders Equity [Line Items]            
Vesting period, year   3 years        
Performance Shares [Member]            
Stockholders Equity [Line Items]            
Weighted average grant date fair value per unit   $ 5.73 $ 9.54 $ 14.55    
Fair value of stock vested   $ 0 $ 3,100,000 $ 1,000,000    
Performance Shares [Member] | Minimum [Member]            
Stockholders Equity [Line Items]            
Number of shares issued on performance 0.00% 0.00% 0.00%      
Performance Shares [Member] | Maximum [Member]            
Stockholders Equity [Line Items]            
Number of shares issued on performance 100.00% 200.00% 300.00%      
Employee Stock Option            
Stockholders Equity [Line Items]            
Contractual term   10 years        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value   $ 2,000,000        
Intrinsic value of options exercised       5,300,000    
Equity-based compensation   $ 0 $ 0 $ 0    
Weighted average grant date fair value per unit   $ 9.16 $ 11.27 $ 12.17    
Employee Stock Option | Minimum [Member]            
Stockholders Equity [Line Items]            
Vesting period, year   5 years        
2020 Executive Inducement Awards [Member]            
Stockholders Equity [Line Items]            
Number of common stock authorizing for issuance   1.7     24.5 8.0